Observing how dry age-related macular degeneration progresses in Chinese adults
Follows Chinese adults with dry macular degeneration to track how their eye disease develops.
Plain-language title generated from the registry record
Registry title: Observation of the Natural Course of Age-related Macular Degeneration
Key facts
- Where
- Shanghai, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 85 years old?
Source: NCT05418231, who can take part
Where in China
- Shanghai General Hospital, Shanghai Jiao Tong UniversityShanghai, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Trial code
- NCT05418231
- Record updated
- 14 June 2022
- Original description
This research will study natural course of dry AMD in Chinese population, screen fundus imaging indicators for patients with Chinese dry AMD, describe the clinical features of Chinese patients with dry AMD, and obtain a biological sample library of dry AMD mainly in China.Read full original descriptionShow less
Observation of the Natural Course of Dry Age-related Macular Degeneration
This research will study natural course of dry AMD in Chinese population, screen fundus imaging indicators for patients with Chinese dry AMD, describe the clinical features of Chinese patients with dry AMD, and obtain a biological sample library of dry AMD mainly in China.
Inclusion: 50-85 yrs male or female AMD patients; Dry-AMD patients in either early, intermediate, or intermediate-to-late stage confirmed by fundus examinations.
Exclusion: Long-term uses of medications that are associated with retinal or neural toxicities; Received cataract surgery in 3 months; Any eye with disease that would interfere with the retinal examinations; Other conditions: diseases that causes less than 5 years survival; any condition that causes high risk of drop-out, or low compliance, for instance cognition disorder; have been involved in other trial that interfere with the current visit plan; taking other angiogenesis Inhibitors drugs for treating cancer; Other conditions not suitable for the current study; Research eye with CNV or high myopia; Surgeries that may interfere with AMD evaluation; IOP more than 26 mmHg.